5lyh
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='5lyh' size='340' side='right' caption='[[5lyh]], [[Resolution|resolution]] 2.17Å' scene=''> | <StructureSection load='5lyh' size='340' side='right' caption='[[5lyh]], [[Resolution|resolution]] 2.17Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5lyh]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5LYH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5LYH FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5lyh]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5LYH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5LYH FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7B8:3-[2-[4-[2-[[4-[(3-AMINOCARBONYLPHENYL)AMINO]-4-OXIDANYLIDENE-BUTANOYL]AMINO]ETHYL]-1,2,3-TRIAZOL-1-YL]ETHYLSULFAMOYL]BENZOIC+ACID'>7B8</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7B8:3-[2-[4-[2-[[4-[(3-AMINOCARBONYLPHENYL)AMINO]-4-OXIDANYLIDENE-BUTANOYL]AMINO]ETHYL]-1,2,3-TRIAZOL-1-YL]ETHYLSULFAMOYL]BENZOIC+ACID'>7B8</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5lxp|5lxp]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5lxp|5lxp]]</td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PARP14, BAL2, KIAA1268 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] </span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5lyh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5lyh OCA], [http://pdbe.org/5lyh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5lyh RCSB], [http://www.ebi.ac.uk/pdbsum/5lyh PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5lyh ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5lyh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5lyh OCA], [http://pdbe.org/5lyh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5lyh RCSB], [http://www.ebi.ac.uk/pdbsum/5lyh PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5lyh ProSAT]</span></td></tr> | ||
| Line 24: | Line 25: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
[[Category: Karlberg, T]] | [[Category: Karlberg, T]] | ||
[[Category: Schuler, H]] | [[Category: Schuler, H]] | ||
Revision as of 20:39, 24 January 2018
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H10
| |||||||||||
